Prestige Consmr Healthcare Stock Price, News & Analysis

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a consumer healthcare products company that markets, sells, manufactures and distributes branded over-the-counter (OTC) items. According to the company’s public disclosures, Prestige focuses on consumer healthcare products sold through retail outlets in the U.S. and Canada, Australia, and certain other international markets. Its business centers on established OTC brands across multiple everyday health categories.

The company is associated with the Pharmaceutical Preparation Manufacturing industry within the broader manufacturing sector. Prestige describes itself as a consumer healthcare products company rather than a prescription drug developer, emphasizing OTC products that are used for common health and personal care needs.

Brand portfolio and key categories

Prestige Consumer Healthcare reports a diverse portfolio of brands across women’s health, pain relief, eye and ear care, oral care, motion sickness, gastrointestinal care, pediatric OTC, diaper rash, lice treatment, earwax removal, antacids, rehydration, and nasal and sinus care. The company repeatedly highlights the following brands in its investor and news communications:

• Women’s health: Monistat® and Summer’s Eve® women’s health products.
• Pain relief: BC® and Goody's® pain relievers.
• Eye care: Clear Eyes® and TheraTears® eye care products.
• Specialty oral care: DenTek® specialty oral care products.
• Motion sickness: Dramamine® motion sickness treatments.
• GI and rectal care: Fleet® enemas and glycerin suppositories.
• Cough, cold and sore throat: Chloraseptic® and Luden's® sore throat treatments and drops.
• Dermatological care: Compound W® wart treatments.
• Pediatric OTC: Little Remedies® pediatric over-the-counter products.
• Diaper rash: Boudreaux’s Butt Paste® diaper rash ointments.
• Lice treatment: Nix® lice treatment.
• Ear care: Debrox® earwax remover.
• Antacid (Canada): Gaviscon® antacid in Canada.
• Rehydration and nasal care (Australia): Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.

These brands position Prestige in multiple OTC segments rather than concentrating on a single therapeutic area. The company’s public commentary also references category performance such as gastrointestinal, women’s health, cough and cold, and eye and ear care.

Geographic focus and segments

Prestige Consumer Healthcare reports activity primarily in North America and selected international markets. In its earnings releases, the company discusses two reporting segments:

• North American OTC Healthcare: This segment includes OTC healthcare products sold in the U.S. and Canada. The company’s disclosures indicate that this segment covers categories such as gastrointestinal, women’s health, cough and cold, and eye and ear care, with brands including Summer’s Eve, Dramamine, Fleet and Clear Eyes mentioned in connection with segment performance.
• International OTC Healthcare: This segment covers markets outside North America, with company commentary highlighting growth in Australia and the role of brands such as Hydralyte® and the Fess® nasal and sinus care line.

Prestige states that it has sales throughout the U.S. and Canada, Australia, and certain other international markets, reflecting a footprint that extends beyond a single country but remains focused on OTC consumer health products.

Business activities and operations

In its news releases, Prestige Consumer Healthcare states that it markets, sells, manufactures and distributes its consumer healthcare products to retail outlets. This indicates that the company is involved in multiple parts of the value chain for its OTC brands, including production and distribution, rather than acting solely as a marketing organization.

The company also discloses that one of its subsidiaries, Medtech Products Inc., is responsible for certain branded products such as Little Remedies® Honey Cough Syrup. Medtech issued a voluntary nationwide recall of specific lots of Little Remedies Honey Cough Syrup due to microbial contamination and loss of shelf stability, underscoring that product quality and regulatory compliance are important aspects of Prestige’s operations.

Financial reporting and public company status

Prestige Consumer Healthcare Inc. files periodic reports and current reports with the U.S. Securities and Exchange Commission (SEC). The company trades on the New York Stock Exchange under the symbol PBH and issues quarterly and annual earnings releases that discuss revenues, net income, earnings per share, free cash flow, leverage, and segment performance. The company also provides non-GAAP financial measures, such as adjusted net income, adjusted diluted earnings per share, and free cash flow, and reconciles these to GAAP metrics in its earnings materials.

Recent SEC Form 8-K filings describe the release of quarterly financial results and the use of investor presentations. Another Form 8-K details a definitive agreement by a Prestige subsidiary to acquire Pillar5 Pharma Inc., a sterile ophthalmic manufacturer and current Clear Eyes® supplier, subject to specified closing conditions. This transaction is described as part of a long-term strategy to expand eye care production capacity.

Risk, regulation and product stewardship

Prestige’s public disclosures reference factors that can affect its performance, including business and economic conditions, consumer trends, advertising and marketing effectiveness, foreign exchange, competitive pressures, and the ability of its manufacturing operations and third-party manufacturers and logistics providers to meet demand and manage costs. The company also notes the role of tariffs, labor shortages, inflation and geopolitical conditions in its forward-looking statements.

The voluntary recall of certain lots of Little Remedies Honey Cough Syrup by Medtech Products Inc., a Prestige company, illustrates the regulatory environment in which the company operates. The recall was conducted with the knowledge of the U.S. Food and Drug Administration and included guidance for consumers on potential health effects and how to seek refunds or report adverse events.

Investor communications and events

Prestige Consumer Healthcare regularly announces the timing of its quarterly earnings releases and related conference calls. The company also participates in investor conferences, such as consumer staples and consumer growth and e-commerce conferences, and makes slide presentations available via webcasts. These activities are described in its press releases and SEC Form 8-K filings, which also note that investor presentations are intended to be considered in the context of the company’s SEC filings and other public announcements.

FAQs about Prestige Consumer Healthcare Inc. (PBH)

• What does Prestige Consumer Healthcare Inc. do?
  Prestige Consumer Healthcare Inc. markets, sells, manufactures and distributes consumer healthcare products to retail outlets. According to its public statements, the company focuses on over-the-counter healthcare brands across categories such as women’s health, pain relief, eye and ear care, gastrointestinal care, pediatric OTC, and related consumer health segments.
• Which brands are associated with Prestige Consumer Healthcare?
  The company lists a portfolio that includes Monistat® and Summer’s Eve® women’s health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric OTC products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® and Fess® products in Australia.
• In which markets does Prestige Consumer Healthcare operate?
  Prestige states that it has sales throughout the U.S. and Canada, Australia, and certain other international markets. Its reporting segments are described as North American OTC Healthcare and International OTC Healthcare.
• How is Prestige Consumer Healthcare classified by industry?
  Based on the provided classification, Prestige Consumer Healthcare Inc. operates in the Pharmaceutical Preparation Manufacturing industry within the manufacturing sector. In its own disclosures, the company describes itself as a consumer healthcare products company focused on OTC brands.
• On which exchange is PBH listed?
  Prestige Consumer Healthcare Inc. is listed on the New York Stock Exchange under the ticker symbol PBH, as referenced in multiple company press releases and SEC filings.
• What are Prestige’s main reporting segments?
  In its earnings releases, Prestige identifies two segments: North American OTC Healthcare, which covers OTC products sold in the U.S. and Canada, and International OTC Healthcare, which includes markets such as Australia and other international territories.
• Has Prestige Consumer Healthcare been involved in product recalls?
  Yes. Medtech Products Inc., described as a Prestige Consumer Healthcare Inc. company, voluntarily recalled specific lots of Little Remedies® Honey Cough Syrup due to the presence of Bacillus cereus and loss of shelf stability. The recall was conducted with the knowledge of the U.S. Food and Drug Administration and applied to certain lots distributed in the United States.
• What is the Pillar5 Pharma transaction mentioned in Prestige’s disclosures?
  According to a Form 8-K, a wholly owned indirect subsidiary of Prestige entered into a definitive share purchase agreement to acquire all of the shares of Pillar5 Pharma Inc., a Canadian company described as a leading sterile ophthalmic manufacturer and current Clear Eyes® supplier, from ANJAC SAS. The transaction is subject to specified conditions and is intended to support eye care production capacity.
• How does Prestige communicate with investors?
  Prestige issues press releases announcing quarterly and annual financial results, provides earnings conference calls with live webcasts and replays, and participates in investor conferences. The company also furnishes investor presentations as exhibits to Form 8-K filings, which it expects to use in meetings with investors and analysts.
• What risks does Prestige highlight in its forward-looking statements?
  In its news releases, Prestige cites factors such as business and economic conditions, tariffs and trade actions, labor shortages, inflation, geopolitical instability, consumer trends, advertising and marketing effectiveness, new product development, customer inventory management, foreign exchange, competitive pressures, and the ability of its own and third-party manufacturing and logistics operations to meet demand and manage costs.